VK
Vijay Kumar Srivastava
About Vijay Kumar Srivastava
Data last updated:
Vijay Kumar Srivastava is a Director at Uvmax Laboratories Private Limited (since 2021) and Director at Aironax Pharmaceuticals Private Limited (since 2019). The companies operate in Chemicals and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.34 Cr; the largest is Uvmax Laboratories Private Limited at ₹69.1 Lakh (FY 2025). Earlier, Vijay Kumar Srivastava was a Director at Uvmax Pharma Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Uvmax Laboratories Private Limited U24230HR2021PTC093492 | Director | 09 Mar 2021 | 2021 | ₹69.1 Lakh (FY 2025) | Active |
| Aironax Pharmaceuticals Private Limited U24239GJ2019PTC107343 | Director | 29 Mar 2019 | 2019 | ₹65.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Uvmax Pharma Private Limited U24233UP2013PTC059704 | Director | 23 Sep 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vijay Kumar Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Usha Srivastava | 09098454 | Uvmax Laboratories Private Limited | Director |
| Jaya Rani Sriwastava | 08487850 | Aironax Pharmaceuticals Private Limited | Additional Director |
| Vivek Shrivastav | 08406059 | Aironax Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Kumar Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Kumar Srivastava
Vijay Kumar Srivastava currently holds 2 directorships: Uvmax Laboratories Private Limited (Director, since 09 Mar 2021, revenue ₹69.1 Lakh (FY 2025)); Aironax Pharmaceuticals Private Limited (Director, since 29 Mar 2019, revenue ₹65.2 Lakh (FY 2025)).
Vijay Kumar Srivastava was first appointed on 23 Sep 2013 as Director at Uvmax Pharma Private Limited. The most recent appointment on record is 09 Mar 2021 at Uvmax Laboratories Private Limited.
The 2 current companies of Vijay Kumar Srivastava that report revenue have a combined latest revenue of ₹1.34 Cr: Uvmax Laboratories Private Limited ₹69.1 Lakh (FY 2025); Aironax Pharmaceuticals Private Limited ₹65.2 Lakh (FY 2025).
Vijay Kumar Srivastava held 1 earlier board appointment: Uvmax Pharma Private Limited (Director, from 23 Sep 2013).
The current boards of Vijay Kumar Srivastava's companies include Usha Srivastava (Uvmax Laboratories Private Limited), Jaya Rani Sriwastava (Aironax Pharmaceuticals Private Limited), Vivek Shrivastav (Aironax Pharmaceuticals Private Limited).